November 2026

November is Pancreatic Cancer Awareness Month

A critical time dedicated to shedding light on one of the most challenging health crises of our time, and to sharing how innovations in cancer screening are helping rewrite the narrative.

Pancreatic cancer is notoriously difficult to catch early because symptoms rarely appear until the disease has reached advanced stages. Today, we want to share how innovations in cancer screening, specifically Multi-Cancer Early Detection (MCED) technology, are helping rewrite that narrative.

The Silent Challenge of Pancreatic Cancer

Unlike breast, cervical, or colorectal cancers, there has historically been no standard, population-wide screening method for pancreatic cancer.

The Galleri test screens for a signal shared by many cancers with a single blood draw.Learn how multi-cancer early detection works and who it is for.
Learn About Galleri
🌟 Patient Spotlight

Roger's Early Detection Story

" My radiologist called just to tell me I was the luckiest person he had ever met, to have detected pancreatic cancer at an early stage. He said I never would have had symptoms or known about it until it was at a much more advanced stage.
— RogerGalleri Test Patient
+
Active and Symptom-Free: Roger considered himself healthy and active when he chose to take the Galleri test as a proactive health measure.

Gift of Galleri

Share a seasonal Health Gift

Resources and messaging to support your wellness initiatives and encourage members to share a seasonal “Health Gift” with their loved ones.

Give the Gift of Galleri
50+
Cancers screened for with a single early-detection blood draw
Multi-Cancer Early DetectionSingle blood drawProactive screening

Early detection can change the story.

Pancreatic cancer rarely shows symptoms early. Proactive screening with the Galleri multi-cancer early detection test is one way to get ahead of it.